#SCREEN MARKER TOOL NOT CENTERED FULL#

The 853/854/855 field is handled as part of the acquisitions process and managed in the following manner:.The normalization task MARC 21 Expand Holding By 863/4/5 Task automatically generates the 863/864/865 field based on the existence and arrival of items linked to the 853/854/855 field in the holdings record.The normalization task MARC 21 Expand Holding By 866/7/8 Task (previously called marc21ExpandHoldingBy86XTask) uses the combination of the existing 853/854/855 field and the 863/864/865 field (automatically generated or manually entered) to create an 866/867/868 summary holdings field.The automatic generation of these fields is handled in the following manner: Linked Data – See Using Linked Data While Working with Bibliographic Records for more information.You can select any error in red (not overridable) or warning in yellow (overridable) to link directly to the field identified by the alert. Alerts – This tab contains field, subfield, indicator, and fixed-field, content-level warnings based on the MD registry.Note that the languages in the table are referring to the user's preferred language. See the table below for the sources of the information provided on the Info tab. Info – This tab contains field-sensitive data based on MD registry definitions. For details regarding this tab, see Working with Normalization Rules, Working with Merge Rules, Working with Indication Rules, Working with Brief Record Levels, and Working with Authority Headings Rules. Rules – This tab contains the private and shared normalization, merge, indication, and brief record level rules that you or others created.Network Zone icon - indicates that the record exists in the Network Zone (for institutions working with a Network Zone).Suppressed icon - indicates that the record has been suppressed from external discovery systems, including Primo.Local Repository icon - indicates that the record exists in the local repository.Records are grouped according to type such as MARC 21 bibliographic, MARC 21 holdings, LC subject, LC name, NLM MeSH, Dublin Core, DCAP, MODS, and ETD. The information presented depends on the type of resource being edited.

#SCREEN MARKER TOOL NOT CENTERED FULL#

Records – This tab contains the brief title information (move the mouse over a record and a tool tip displays the full title) and metadata ID linked to the MD record.

For more information, see Working with Record Templates and Expanding a Record from a Template.

Templates – This tab contains templates that enable you to create new records based on a template, or use one of the templates to override existing data.

Moreover, they underscore the applicability of stable strontium as a tool for investigating calcium absorption under various conditions. These findings demonstrate that intestinal strontium absorption has, like intestinal calcium absorption, an active component. The mean bioavailability (true absorption) was 33% for calcium and 19% for strontium (ratio 1.7:1), whereas, after 1,25(OH)2D(3) pretreatment, it was 73 and 43% (ratio 1.7:1), respectively. We studied the effects of 1,25-dihydroxyvitamin D3, a potent enhancer of active intestinal calcium absorption, on the pharmacokinetics of both calcium-45 and strontium in adult male rats, in a short-term dose-finding study and also in a placebo-controlled study in which 12.5 ng 1,25(OH)2D(3)/100 g body weight were applied to assess the long-term pharmacokinetics. Therefore, preclinical screening of this ratio before and after treatment is indispensable for a clinical calcium absorption test based on the use of stable strontium as a marker. Up to now, it is not clear whether this ratio is affected by intervention therapy. The applicability of stable strontium as a marker for measuring intestinal calcium absorption is mainly dependent on the validity of the assumption that calcium and strontium are absorbed with a constant ratio.

Screen marker tool not centered